Related Experiment Video
Updated: Mar 9, 2026

06:07
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
Published on: June 6, 2025
1.4K
Drug-resistant tuberculosis in Naples, 2008-2013
Annalisa Del Giudice1, Alessandro Mustazzolu2, Angelo Iacobino2
1Laboratorio di Microbiologia e Virologia, Ospedali dei Colli, Naples, Italy.
Annali Dell'Istituto Superiore Di Sanita
|December 22, 2016
Summary
Multidrug-resistant tuberculosis (MDR-TB) cases rose in Naples between 2008 and 2013, primarily affecting migrants. This highlights the need for enhanced diagnosis and treatment strategies for these populations.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Drug-resistant tuberculosis (TB) poses a significant global health challenge.
- Limited data exists on drug-resistant TB trends in Southern Italy.
- Naples, Southern Italy's largest city, was the focus of this retrospective study.
Purpose of the Study:
- To investigate the prevalence and trends of drug-resistant tuberculosis in Naples from 2008 to 2013.
- To identify the demographic and geographic origins of drug-resistant TB cases.
- To assess resistance patterns to first- and second-line anti-TB drugs.
Main Methods:
- Retrospective analysis of Mycobacterium tuberculosis strains isolated between 2008 and 2013.
- Determination of drug resistance profiles for first- and second-line anti-TB medications.
- Analysis of patient origin, including Italian-born individuals and migrants.
Main Results:
- A total of 690 Mycobacterium tuberculosis strains were analyzed.
- Multidrug-resistant tuberculosis (MDR-TB) increased from 2008 to 2013.
- MDR-TB strains were predominantly found in migrants (77.4%), originating from 41 countries. Overall MDR-TB prevalence was 4.5%, with higher rates among individuals from Former Soviet Union countries (22.4%).
- High resistance rates were observed for second-line drugs, including kanamycin, ofloxacin, and capreomycin.
Conclusions:
- MDR-TB incidence in Naples showed an upward trend between 2008 and 2013.
- Migrant populations were disproportionately affected by MDR-TB.
- Intensified diagnostic and therapeutic interventions are crucial for migrant populations in Naples to control MDR-TB.
Related Concept Videos
Pulmonary Tuberculosis V
719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Pulmonary Tuberculosis IV
592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
Development of Antibiotic Resistance
1.7K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K

